Alexander's, Inc. ALX
Alexander's, Inc., a real estate investment trust, possesses a portfolio comprising seven properties located across the broader New York City metropolitan region.
Business overview written from the company's own Form 10-K (Item 1), filed 2026-02-09 — refreshed whenever it files a new one. The figures above are current; see its SEC filings. ✓ From the 10-K
Plain-English: the Snapshot is the quick read — what it pays you (yield, dividend), how its cash flow looks (FFO/AFFO, Price/OCF) and how much debt it carries. Switch to Expert in the header to hide these explanations.
Snapshot
Yield uses the latest declared dividend, annualized (latest regular payout × frequency; special/liquidating distributions excluded) — an announced-but-not-yet-declared change isn't reflected until it has an ex-date. FFO, AFFO and Net debt / Adj. EBITDA are the company's reported figures from its latest earnings 8-K. Price/OCF and payout use GAAP operating cash flow. NAV premium and credit ratings have no free source yet. See Methodology.
$10,000 invested
Illustrative income only, at today's price and latest declared dividend — it excludes price changes, dividend cuts and taxes. Not a forecast.
Model ALX yourself — any amount, shares, per-payment & a multi-year DRIP projection →
Balance sheet (latest FY: 2025)
Debt-maturity ladder, fixed/floating split, secured/unsecured and coverage ratios come from the supplemental — not yet ingested.
Financial history
| FY | Revenue | Net income | D&A | EBITDA | Op. cash flow |
|---|---|---|---|---|---|
| 2025 | $213.18M | $28.22M | $35.06M | $114.91M | $73.44M |
| 2024 | $226.37M | $43.44M | $37.90M | $144.16M | $54.11M |
| 2023 | $224.96M | $102.41M | $32.90M | $117.41M | $109.11M |
| 2022 | $205.81M | $57.63M | $31.45M | $117.69M | $102.55M |
| 2021 | $206.15M | $132.93M | $34.59M | $184.86M | $118.47M |
| 2020 | $199.14M | $41.94M | $26.50M | $98.57M | $78.07M |
Dividends
Recent regular dividends per share (special distributions excluded), oldest → newest.
| Ex-date | Record | Payment | Declared | Amount | Freq. |
|---|---|---|---|---|---|
| 2026-05-11 | 2026-05-11 | 2026-05-29 | 2026-04-29 | $4.50 | Quarterly |
| 2026-02-17 | 2026-02-17 | 2026-02-27 | 2026-02-04 | $4.50 | Quarterly |
| 2025-11-10 | 2025-11-10 | 2025-11-28 | 2025-10-29 | $4.50 | Quarterly |
| 2025-08-11 | 2025-08-11 | 2025-08-29 | 2025-07-30 | $4.50 | Quarterly |
| 2025-05-12 | 2025-05-12 | 2025-05-30 | 2025-04-30 | $4.50 | Quarterly |
| 2025-02-18 | 2025-02-18 | 2025-02-28 | 2025-02-05 | $4.50 | Quarterly |
| 2024-11-08 | 2024-11-11 | 2024-11-29 | 2024-10-30 | $4.50 | Quarterly |
| 2024-08-12 | 2024-08-12 | 2024-08-30 | 2024-07-31 | $4.50 | Quarterly |
| 2024-05-10 | 2024-05-13 | 2024-05-31 | 2024-05-01 | $4.50 | Quarterly |
| 2024-02-16 | 2024-02-20 | 2024-03-01 | 2024-02-07 | $4.50 | Quarterly |
| 2023-11-03 | 2023-11-06 | 2023-11-17 | 2023-10-25 | $4.50 | Quarterly |
| 2023-08-04 | 2023-08-07 | 2023-08-18 | 2023-07-26 | $4.50 | Quarterly |
| 2023-05-05 | 2023-05-08 | 2023-05-19 | 2023-04-26 | $4.50 | Quarterly |
| 2023-01-27 | 2023-01-30 | 2023-02-10 | 2023-01-18 | $4.50 | Quarterly |
| 2022-11-04 | 2022-11-07 | 2022-11-18 | 2022-10-26 | $4.50 | Quarterly |
| 2022-08-05 | 2022-08-08 | 2022-08-19 | 2022-07-27 | $4.50 | Quarterly |
| 2022-05-06 | 2022-05-09 | 2022-05-20 | 2022-04-27 | $4.50 | Quarterly |
| 2022-01-28 | 2022-01-31 | 2022-02-11 | 2022-01-19 | $4.50 | Quarterly |
| 2021-11-05 | 2021-11-08 | 2021-11-19 | 2021-10-27 | $4.50 | Quarterly |
| 2021-08-06 | 2021-08-09 | 2021-08-20 | 2021-07-28 | $4.50 | Quarterly |
| 2021-05-07 | 2021-05-10 | 2021-05-21 | 2021-04-28 | $4.50 | Quarterly |
| 2021-01-29 | 2021-02-01 | 2021-02-12 | 2021-01-20 | $4.50 | Quarterly |
| 2020-11-06 | 2020-11-09 | 2020-11-20 | 2020-10-28 | $4.50 | Quarterly |
| 2020-08-07 | 2020-08-10 | 2020-08-21 | 2020-07-29 | $4.50 | Quarterly |
Coverage (payout of operating cash flow): 125.85%. Tax-character split (ordinary / 199A / capital gain / return of capital) — not disclosed (requires the annual allocation release).
Recent news — ALX
ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules
ALX Oncology Appoints Scott Garland as Chairman of the Board and Michael Listgarten as General Counsel
Alexander’s Leases 135,000 Square Feet to Target at its Rego Park Shopping Center; Center is 99% Leased
Alexander's Leases 135,000 Square Feet to Target at its Rego Park Shopping Center; Center is 99% Leased
Greenridge Exploration Fully Exercises Option for 100% Interest in the Carpenter Lake Uranium Project in Athabasca Basin, Saskatchewan
ALX Oncology to Present at the 2026 Jefferies Global Healthcare Conference in New York
Alexander’s Completes Sale of Rego Park I
Alexander's Completes Sale of Rego Park I
Headlines via Financial Modeling Prep; links open the original publisher in a new tab. Not an endorsement or investment advice.
Other Retail REITs
Same-store NOI, occupancy, leasing/WALT, top tenants, external-manager fees, development pipeline and (for non-traded vehicles) share-class fees, redemption/gating and NAV methodology are planned modules sourced from supplementals and prospectuses.